Hemophilia, low bone mass, and osteopenia/osteoporosis

Transfusion and Apheresis Science

Volumn 38, Issue 1, 2008, Pages 33-40

  Kovacs, Christopher S ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CONJUGATED ESTROGEN; ESTROGEN; ETIDRONIC ACID; IBANDRONIC ACID; ORAL CONTRACEPTIVE AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RECLAST; RISEDRONIC ACID; STRONTIUM RANELATE; TESTOSTERONE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MASS; ESTROGEN THERAPY; HEMOPHILIA; HUMAN; JOINT MOBILIZATION; ORAL CONTRACEPTION; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PHYSIOTHERAPIST; SHORT STATURE; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION;

BONE DENSITY; BONE DISEASES, METABOLIC; DISEASE PROGRESSION; FEMALE; HEMOPHILIA A; HUMANS; MALE; OSTEOPOROSIS;

EID: 40849137602     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.12.003     Document Type: Article

References (36)

1. Barnes C., Wong P., Egan B., Speller T., Cameron F., Jones G., et al. Reduced bone density among children with severe hemophilia. Pediatrics 114 (2004) e177-e181
2. Nelson D.A., Norris S.A., and Gilsanz V. Chidhood and adolescence. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), ASBMR Press, Washington, DC 55-63
3. Hui S.L., Slemenda C.W., and Johnston Jr. C.C. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81 (1988) 1804-1809
4. Kanis J.A., Johnell O., Oden A., Dawson A., De Laet C., and Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12 (2001) 989-995
5. Kanis J.A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046
6. ISCD. Updated 2005 official positions of the international society for clinical densitometry (2005), ISCD, West Hartford, CT
7. Siminoski K., Leslie W.D., Frame H., Hodsman A., Josse R.G., Khan A., et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56 (2005) 178-188
8. Miller P.D., and Leonard M.B. Clinical use of bone mass measurements in adults for the assessment and management of osteoporosis. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), ASBMR Press, Washington, DC 150-161
9. Heaney R.P. BMD: the problem. Osteoporos Int 16 (2005) 1013-1015
10. Welten D.C., Kemper H.C., Post G.B., Van Mechelen W., Twisk J., Lips P., et al. Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res 9 (1994) 1089-1096
11. Valimaki M.J., Karkkainen M., Lamberg-Allardt C., Laitinen K., Alhava E., Heikkinen J., et al. Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular risk in young finns study group. BMJ 309 (1994) 230-235
12. Wolff I., van Croonenborg J.J., Kemper H.C., Kostense P.J., and Twisk J.W. The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9 (1999) 1-12
13. Kelley G.A., Kelley K.S., and Tran Z.V. Exercise and bone mineral density in men: a meta-analysis. J Appl Physiol 88 (2000) 1730-1736
14. Felson D.T., Zhang Y., Hannan M.T., and Anderson J.J. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8 (1993) 567-573
15. Castro J.P., Joseph L.A., Shin J.J., Arora S.K., Nicasio J., Shatzkes J., et al. Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study. Nutr Metab (Lond) 2 (2005) 9
16. Heaney R.P. Nutrition and osteoporosis. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism (2006), ASBMR Press, Washington, DC 255-257
17. Dawson-Hughes B. Calcium and vitamin D. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), ASBMR Press, Washington, DC 257-259
18. Black D., and Rosen C.J. Bisphosphonates for the prevention and treatment of osteoporosis. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), ASBMR Press, Washington, DC 277-282
19. Cosman F. PTH treatment for osteoporosis. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), ASBMR Press, Washington, DC 285-290
20. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New Engl J Med 350 (2004) 459-468
21. Blake G.M., and Fogelman I. Effect of bone strontium on BMD measurements. J Clin Densitom 10 (2007) 34-38
22. Nair A.P., Jijina F., Ghosh K., Madkaikar M., Shrikhande M., and Nema M. Osteoporosis in young haemophiliacs from western India. Am J Hematol 82 (2007) 453-457
23. Wallny T.A., Scholz D.T., Oldenburg J., Nicolay C., Ezziddin S., Pennekamp P.H., et al. Osteoporosis in haemophilia - an underestimated comorbidity?. Haemophilia 13 (2007) 79-84
24. Tuominen J.T., Impivaara O., Puukka P., and Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22 (1999) 1196-1200
25. Hampson G., Evans C., Petitt R.J., Evans W.D., Woodhead S.J., Peters J.R., et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 41 (1998) 1314-1320
26. Strotmeyer E.S., Cauley J.A., Schwartz A.V., Nevitt M.C., Resnick H.E., Zmuda J.M., et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: the health, aging, and body composition study. J Bone Miner Res 19 (2004) 1084-1091
27. Isaia G.C., Ardissone P., Di Stefano M., Ferrari D., Martina V., Porta M., et al. Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 36 (1999) 35-38
28. Forsen L., Meyer H.E., Midthjell K., and Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42 (1999) 920-925
29. Schwartz A.V., Sellmeyer D.E., Strotmeyer E.S., Tylavsky F.A., Feingold K.R., Resnick H.E., et al. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res 20 (2005) 596-603
30. Nicodemus K.K., and Folsom A.R. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24 (2001) 1192-1197
31. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., Cauley J.A., Tabor H.K., Schreiner P.J., et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86 (2001) 32-38
32. Khan S.A., Kanis J.A., Vasikaran S., Kline W.F., Matuszewski B.K., McCloskey E.V., et al. Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 12 (1997) 1700-1707
33. Yarom N., Yahalom R., Shoshani Y., Hamed W., Regev E., and Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18 (2007) 1363-1370
34. Wang E.P., Kaban L.B., Strewler G.J., Raje N., and Troulis M.J. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65 (2007) 1328-1331
35. Van den Wyngaert T., Huizing M.T., and Vermorken J.B. Osteonecrosis of the jaw related to the use of bisphosphonates. Curr Opin Oncol 19 (2007) 315-322
36. Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research. J Bone Miner Res 22 (2007) 1479-1491